For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Teladoc Health Inc (NYSE: TDOC) closed the day trading at $13.11 down -8.51% from the previous closing price of $14.33. In other words, the price has decreased by -$8.51 from its previous closing price. On the day, 16.52 million shares were traded.
Ratios:
For a better understanding of TDOC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.80. For the most recent quarter (mrq), Quick Ratio is recorded 1.65 and its Current Ratio is at 1.69. In the meantime, Its Debt-to-Equity ratio is 1.05 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on November 15, 2024, initiated with a Buy rating and assigned the stock a target price of $14.
On September 17, 2024, Jefferies reiterated its Hold rating and also lowered its target price recommendation from $8 to $10.
On February 29, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $22.Cantor Fitzgerald initiated its Overweight rating on February 29, 2024, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 03 ’25 when Nanis Nikolaos P. bought 502 shares for $9.33 per share.
Waters Michael Willem bought 4,652 shares of TDOC for $47,823 on Dec 16 ’24. On Dec 03 ’24, another insider, Nueno Carlos, who serves as the President, International of the company, sold 2,890 shares for $11.23 each. As a result, the insider received 32,455 and left with 0 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.87 while its Price-to-Book (P/B) ratio in mrq is 1.50.
Stock Price History:
Over the past 52 weeks, TDOC has reached a high of $21.74, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is 25.36%, while the 200-Day Moving Average is calculated to be 34.83%.
Shares Statistics:
A total of 171.94M shares are outstanding, with a floating share count of 170.42M. Insiders hold about 1.01% of the company’s shares, while institutions hold 74.66% stake in the company.
Earnings Estimates
Current recommendations for the stock of the company come from 3.0 analysts. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.31 and low estimates of -$0.46.
Analysts are recommending an EPS of between -$1.09 and -$1.31 for the fiscal current year, implying an average EPS of -$1.19. EPS for the following year is -$1.03, with 3.0 analysts recommending between -$0.82 and -$1.31.
Revenue Estimates
25 analysts predict $639.44M in revenue for the current quarter. It ranges from a high estimate of $673.75M to a low estimate of $632.34M. As of the current estimate, Teladoc Health Inc’s year-ago sales were $660.53MFor the next quarter, 25 analysts are estimating revenue of $633.03M. There is a high estimate of $654.78M for the next quarter, whereas the lowest estimate is $617.72M.
A total of 25 analysts have provided revenue estimates for TDOC’s current fiscal year. The highest revenue estimate was $2.6B, while the lowest revenue estimate was $2.56B, resulting in an average revenue estimate of $2.57B. In the same quarter a year ago, actual revenue was $2.6BBased on 25 analysts’ estimates, the company’s revenue will be $2.54B in the next fiscal year. The high estimate is $2.6B and the low estimate is $2.48B.
